ArticleClinical cancer research : an official journal of the American Association for Cancer Research2026
Correction: A Single-Arm Phase 2 Trial of Doxorubicin Plus Zalifrelimab (Anti-CTLA-4 Antibody) and Balstilimab (Anti-PD-1 Antibody) in Advanced/Metastatic Soft Tissue Sarcomas.
Breelyn A Wilky et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.